Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5
Defining Administration Complexity by the Drug, Not the Diagnosis
Therapeutics for COVID-19: An update from ACR Convergence 2021
The Great Debate: Belimumab vs. Voclosporin in Lupus Nephritis
FDA Approves First Interchangeable Biosimilar to Adalimumab, Plus a Combination Drug Approved
FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira
A Dematologist’s Perspective on Choosing an Anti-Psoriatic Drug
FDA Approves Avacopan for the Treatment of ANCA-Associated Vasculitis
Guselkumab Promising in Patients with PsA
- 1
- 2
- 3
- …
- 35
- Next Page »